Renal involvement as a unique manifestation of hemophagocytic syndrome
- PMID: 36275824
- PMCID: PMC9579315
- DOI: 10.3389/fmed.2022.796121
Renal involvement as a unique manifestation of hemophagocytic syndrome
Abstract
Renal-limited hemophagocytic syndrome (HPS) is a rare clinical setting characterized by abnormal activation of the immune system. Fever associated with pancytopenia, hepatosplenomegaly with liver dysfunction, and hypofibrinogenemia are usually observed in HPS. From a histological level, the presence of non-malignant macrophages infiltrating bone marrow and organs represents the hallmark of this condition. Non-malignant macrophages are associated with phagocytizing activities involving other blood cells. While primary HPS is usually associated with inherited dysregulation of the immune system, secondary HPS usually occurs in the context of infection or is linked to a neoplastic process. Clinical presentation varies and can potentially lead to life-threatening settings. While renal involvement has frequently been reported, however, detailed descriptions of the kidney manifestations of HPS are lacking. More critically, the diagnosis of HPS is rarely supported by renal biopsy specimens. We report four rare cases of biopsy-proven renal-limited HPS in patients presenting with acute kidney injury (AKI). The available evidence on this topic is critically discussed in light of the possible emergence of an autonomous entity characterized by an isolated kidney involvement.
Keywords: acute kidney injury; autoinflammatory diseases; hemophagocytic lymphohistiocytosis; hemophagocytic syndrome; macrophage activation syndrome.
Copyright © 2022 Roccatello, Sciascia, Barreca, Naretto, Alpa, Quattrocchio, Radin and Fenoglio.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Hines MR, von Bahr Greenwood T, Beutel G, Beutel K, Hays JA, Horne A, et al. . Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults. Crit Care Med. (2022) 50:860–72. 10.1097/CCM.0000000000005361 - DOI - PubMed
